APA (7th ed.) Citation

S, G., RT, S., C, J., V, F., J, M., K, A., . . . P, K. (2024). Systemic chemokine-modulatory regimen combined with neoadjuvant chemotherapy in patients with triple-negative breast cancer. Journal for immunotherapy of cancer, 12(11), . https://doi.org/10.1136/jitc-2024-010058

Chicago Style (17th ed.) Citation

S, Gandhi, et al. "Systemic Chemokine-modulatory Regimen Combined with Neoadjuvant Chemotherapy in Patients with Triple-negative Breast Cancer." Journal for Immunotherapy of Cancer 12, no. 11 (2024). https://doi.org/10.1136/jitc-2024-010058.

MLA (9th ed.) Citation

S, Gandhi, et al. "Systemic Chemokine-modulatory Regimen Combined with Neoadjuvant Chemotherapy in Patients with Triple-negative Breast Cancer." Journal for Immunotherapy of Cancer, vol. 12, no. 11, 2024, https://doi.org/10.1136/jitc-2024-010058.